What is Pulmonx Corporation's total revenue?

Pulmonx Corporation (LUNG) reported total revenue of $20.59M in Q1 2026.

How has Pulmonx Corporation's total revenue changed year-over-year?

Pulmonx Corporation's total revenue decreased by 8.7% year-over-year, from $22.54M to $20.59M.

What is the long-term trend for Pulmonx Corporation's total revenue?

Over 4 years (2021 to 2025), Pulmonx Corporation's total revenue has grown at a 16.9% compound annual growth rate (CAGR), from $48.42M to $90.5M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Pulmonx Corporation LUNG Total Revenue

Total Revenue at other companies

Intuitive SurgicalISRG

$2.77B+23.0%

Theravance BiopharmaTBPH

$17.7M+15.0%

LQD

Liquidia CorporationLQDA

$132.87M+4,158%

United TherapeuticsUTHR

$781.5M-1.6%

Viemed Healthcare, Inc.VMD

$75.41M+27.5%

Zevra Therapeutics, Inc.ZVRA

$36.22M+77.5%

Segments

By geography

See full

Europe, Middle-East and Africa (“EMEA”)$6.57M+19.9%

Asia Pacific$707K-74.7%

Other International$51K+34.2%

Other financials

Income statement

See full

Gross profit$16.0M-1.8%

Operating income-$13.0M+11.0%

Net income-$13.7M+5.5%

EPS (diluted)-$0.33+8.3%

Balance sheet

See full

Cash & equivalents$61.0M-2.4%

Total debt$56.3M-1.2%

Total equity$45.8M-41.1%

Total assets$120.0M-20.4%

Cash flow

See full

Operating cash flow-$10.1M+23.6%

CapEx$9.0K-97.0%

Free cash flow-$10.1M+25.3%

Valuation

See full

Market cap$54.91M-47.3%

Enterprise value$50.17M-43.5%

P/S0.6×-0.5×

Profitability

See full

Gross margin75.5%+2.0pp

Operating margin-58.8%-5.8pp

Net margin-60.1%-4.4pp

FCF margin-33.2%-4.4pp

Returns & leverage

See full

Return on equity-86.2%+62.6pp

Debt / equity1.2×+0.5×

Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulmonx Corporation's total revenue?: Pulmonx Corporation (LUNG) reported total revenue of $20.59M in Q1 2026.
How has Pulmonx Corporation's total revenue changed year-over-year?: Pulmonx Corporation's total revenue decreased by 8.7% year-over-year, from $22.54M to $20.59M.
What is the long-term trend for Pulmonx Corporation's total revenue?: Over 4 years (2021 to 2025), Pulmonx Corporation's total revenue has grown at a 16.9% compound annual growth rate (CAGR), from $48.42M to $90.5M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.